TNF and Cowden disease: Biological therapies, including TNF-α inhibitors, have been proven to be effective for inflammatory and fistulizing CD [3,4], such as the anti-TNF-α antibodies adalimumab (ADL) and infliximab (IFX), which have similar efficacies [5].